ALN-SNCA

· Regeneron Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-SNCA, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD) [Phase 1]